SALIX PHARMACEUTICALS INC's ticker is and the CUSIP is 795435AE6. A total of 61 filers reported holding SALIX PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2015 | $1,461,000 | -86.2% | 550,000 | -90.5% | 0.00% | -85.7% |
Q4 2014 | $10,606,000 | +77.0% | 5,818,000 | +134.8% | 0.01% | +75.0% |
Q3 2014 | $5,993,000 | -16.8% | 2,478,000 | -32.5% | 0.00% | -20.0% |
Q2 2014 | $7,202,000 | +642.5% | 3,669,000 | +539.2% | 0.01% | +400.0% |
Q1 2014 | $970,000 | +9.1% | 574,000 | -3.9% | 0.00% | 0.0% |
Q4 2013 | $889,000 | +26.5% | 597,000 | +4.0% | 0.00% | 0.0% |
Q3 2013 | $703,000 | – | 574,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TENOR CAPITAL MANAGEMENT Co., L.P. | 36,001,000 | $95,697,000 | 16.53% |
CAPSTONE INVESTMENT ADVISORS, LLC | 145,320,992 | $386,133,000 | 6.28% |
Verition Fund Management LLC | 18,500,000 | $49,268,000 | 5.72% |
PIPER SANDLER & CO. | 3,750,000 | $9,968,000 | 4.14% |
BERKLEY W R CORP | 25,881,000 | $68,886,000 | 3.58% |
WOLVERINE ASSET MANAGEMENT LLC | 31,256,000 | $83,048,000 | 1.66% |
TT INTERNATIONAL | 760,000 | $2,020,000 | 1.41% |
FARALLON CAPITAL MANAGEMENT LLC | 31,014,000 | $82,372,000 | 1.20% |
CSS LLC/IL | 8,300,000 | $22,057,000 | 1.12% |
SG Americas Securities, LLC | 370,000 | $98,536,000 | 0.59% |